To counteract the tumor metastasis driven by the diminishing of cell junctions, ZO-1, a marker of epithelial cell junctions, counteracts EMT by maintaining tight junctions, preserving endothelial cell polarity, and contributing to cytoskeletal organization [50]. The gene discussed is TJP1; the disease is neoplasm.